Today: March 18, 2018, 10:51 am

Creative Bioarray's New cDNA Sample Enables Deeper Insights into Biological Research

Creative Bioarray today announced its newly updated cDNA Sample to life science community.
Creative Bioarray
Creative Bioarray 2015-11-06 10:51:12
Creative Bioarray, a global leader in the manufacturing of research-use cells including primary cells, tumor cells, stem cells and transformed cells, etc., today launched its newly updated cDNA Sample to life science community. This product can be used in gene expression and cloning studies, gene mutation analysis, analysis of mRNA alternative splicing and other molecular biology fields.

The ability to synthesize DNA from an RNA template, via reverse transcription, enables researchers to study RNA with the same molecular approaches used for DNA investigations. cDNA generated by reverse transcription can be amplified using polymerase chain reaction (PCR). The combination of reverse transcription and PCR (RT-PCR) allows the detection of low abundance RNAs in a sample. Geoffrey M. Cooper, associate dean of the natural sciences and professor of biology at Boston University, explained cDNA in his The Cell.

Creative Bioarray's cDNA is synthesized from a highly pure and intact total RNA. The newest additions include products such as Skin Fibroblast cDNA(TM: ..), Skin Fibroblast cDNA (PD), Skin Fibroblast cDNA (Neurofibromatosis), Bone Marrow Stromal Cell cDNA(Diabetes Type II: ..), just to name a few.

"By supplying the cDNA sample to biologists, we're hoping to further support the development of the life sciences community," stated Sherry W. Corchado, Executive Director of Marketing at Creative Bioarray. "In addition, at Creative Bioarray customers have access to the latest, high quality analytical instruments and discovery tools, enabling them to take their research further and faster -- while saving their cost"

"All products are validated under strict quality assurance and control parameters, providing customers with reliable, quality products for reproducible results with maximum impact." said Dr. Hannah Cole, the senior scientific officer of R&D department of Creative Bioarray.

Click here for more detailed information on cDNA Sample:

About Creative Bioarray:

Found in 2004, Creative Bioarray is an innovative biotechnology company whose mission is to develop unique technologies that provide researchers with the tools to investigate life science.

Creative Bioarray provides a wide range of high quality normal human and animal cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services for the research community. Their products are currently used around the world in the biological laboratories of universities, government institutes, biotechnology and pharmaceutical companies in more than 50 countries and districts.


Phone: 1-631-626-9181

Fax: 1-631-614-7828

Address: 45-1 Ramsey Road, Shirley, NY 11967, USA



1. Cooper, Geoffery M. The Cell: A Molecular Approach. 4th ed. Washington D.C.: ASM Press, 2007. 129-132.

Press Information
Creative Bioarray
45-1 Ramsey Road, Shirley, NY 11967, USA

Steven Rios

# 453 Words
Related Articles
More From Science
Thunder Energies Successfully Submits a Grant Application [..]
Brian Buckley, Operations Manager of Thunder Energies Corporation, a publicly traded company with stock symbol (OTC:TNRG), announces [..]
Tracking Ocean Salinity from Space using Colour
Ocean colour could serve as a reliable proxy for salinity, opening the door for more frequent and detailed measurements. Selangor, [..]
TNRG announces a Contract with an Institutional [..]
Dr. Ruggero M. Santilli, Chief Executive Officer of Thunder Energies Corporation, a publicly traded company with stock symbol (OTC:TNRG), [..]
Rolling in it: Dung Beetles' Taste Preferences [..]
Selangor, Malaysia, Feb 9, 2018 - (ACN Newswire) - The first observational study of a dung beetle species on Langkawi [..]
Thunder Energies Announces New Remote Controls for [..]
Brian Buckley, Operations Manager of Thunder Energies Corporation, a publicly traded company with stock symbol (OTC:TNRG), announces [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.